₹33 in the grey market today. The company's shares are expected to list on leading stock exchanges BSE and NSE on Wednesday, November 16, 2022. “Global health had a better performance in FY22 than it had in the preceding years.
The average occupancy level of beds was 60.50%, while the EBITDA margins were close to 22% in FY22. At the upper price band of the issue, the market cap is almost four times the company's FY22 revenue, whereas the asking p/e is close to 46x (post-fresh issue).
The issue appears to be priced in line with its listed counterparts. We might observe a divide in investors' participation as a result of the conflicting IPOs," said Abhay Doshi, co-founder of UnlistedArena.
Global Health IPO consists of a fresh issue of equity shares aggregating to ₹500 crore and an offer for sale (OFS) of up to 5.08 crore equity shares by the company's shareholders and the promoters.